Issues Surronding Patents for Pharmaceuticals

In: Business and Management

Submitted By sarahsmile
Words 883
Pages 4
Date: August 19, 2011 There are many issues surrounding patents for pharmaceuticals. Some of the more important issues include: * The use of pharmaceuticals makes a major contribution towards the level of care experienced at a doctor and hospital visit. * An increasing number of people are taking drugs to control chronic conditions, so more people have a stake in assuring a productive pharmaceutical industry. * There are some very aggressive marketing practices by major pharmaceutical companies. * There are extremely high out-of-pocket prescription drug expenses for some people. * The rate at which pharmaceutical expenditures have increased over the last ten years brings the industry to the forefront of policy debates over healthcare cost containment. * The instances of government approval of drugs that were shown to have dangerous side effects and the reluctance to remove dangerous drugs from the market. * Frequent prescribing of expensive drugs when evidence suggests that older, less expensive products would be as equally effective.
When firms develop new products, they can apply for a patent. Upon receiving a patent, it prevents other firms from selling that product for twenty years. During the seventeen years, the developing firm can is protected from the competition and can charge higher prices and make large economic profits. Patents foster new inventions by rewarding inventors for the expense and risk of bringing new products to the market.

There is only one firm producing the product so it is a monopoly, the firm's demand curve is identical to the market demand curve. The monopoly firm does not have to worry about competitor's prices so the monopolist will continue to sell units as long as the extra amount he receives by selling an extra unit is greater than his marginal cost. The firm will always set their quantity…...

Similar Documents


...INTELLECTUAL PROPERTY(IP)-This refers to the creations of mind: invetions, literary and artistic works and symbols, names, images and designs used in commerce and trade. IP is divided into two categories- 1-Industrial Property-which includes inventions (Patents, Trademarks, Industrial Designs and Geographical Indications of source) 2-Copyright-which includes literary and artistic works such as novels, poems and plays, films, musical works, artistic works such as drawings, paintings, photographs and sculptures and architectural designs. WHAT ARE IPR’s? Intellectual Property Rights are the rights given to people over the creations of their minds. With rights in hand, through the exploitation of IP, the individuals or the business organizations earn profits either through manufacturing or licensing and which is a reward for their innovative efforts. It also acts as a stimulus to R&D efforts. NEED FOR IPR’S: Michael Porter in his work on “Competitive Advantage” stated that differentiation is a key to business competitiveness. This can achieved through product, experience, technology or way the things are performed and exhibited to satisfy the customers. However, all this amounts to the knowledge which, in today’s highly dynamic and competitive business environment is the key source of competitive strength to the organizations. The need of IPR can be felt because any invention is the intellectual catpital of a firm or an individual which needs to be captured,......

Words: 2571 - Pages: 11

Case Analysis of Global Pharmaceuticals

...The Global Pharmaceutical Industry Case Analysis This case by Sarah Holland and Bernardo Bátiz-Lazostudies studies the evolution of the ethical pharmaceutical industry and analyses the various forces affecting the discovery, development, production, distribution and marketing of prescription drugs. The authors further analyses the critical issues of corporate social responsibility in the industry and the strategies being followed by major pharmaceutical companies and the challenges and opportunities for the future. This case bases its research to find evidence to support or disprove findings of a report published in the Gardiner by analysts at the investment bank of Dresdner Kleinwort Wasserstein which claimed that the world's major drugs companies are operating a business model that is unsustainable and rapidly running out of steam. On the surface however, the pharmaceuticals business seems like the epitome of a modern, mature industry that has found a comfortable way to make profits by the billion. According to the case large pharmaceuticals companies are currently facing the most challenging times since a decade. Even though the industry has made tremendous contributions to human well-being, its roles and actions are still criticized by the media and under constant scrutiny by national governments in their efforts to reduce expenditure in healthcare. Stringent laws and regulations have come in action which has made product approval, pricing and promotions......

Words: 6162 - Pages: 25

Compulsory Licensing and Legal Issues in the Pharmaceutical Sector

...Introduction As the awareness and adoption of patents grows across the globe, we look to evaluate the consequences to society as a result of protection through patents. We will look at both sides objectively – the side of the inventor who has been granted exclusive rights to his/her invention and the other side – whether patents can deny basic social rights such as health to society. As we move further, we will look to understand a global framework (TRIPS) that provides guidelines on intellectual property regulations, the issue of compulsory licenses used by governments to circumvent patent protection and critically analyze specific cases where issuing compulsory licenses may be the need of the hour. What is TRIPS? TRIPS or Trade Related Aspects of Intellectual Property Rights is an agreement administered by the World Trade Organization (WTO). The agreement covers the following broad issues with respect to regulation of intellectual property (IP): • Basic principles that apply to intellectual property rights agreements • Protection to intellectual property rights • enforcement of intellectual property rights across member nations • settling disputes related to intellectual property rights between member nations A key objective of TRIPS is to provide a common set of international rules or guidelines to ensure protection of patents around the world. TRIPS is unique because it binds any country to its system of intellectual property protection if that......

Words: 3881 - Pages: 16

Drug Patents

...Drug patents The role of the patent system in promoting pharmaceutical innovation is widely seen as a tremendous success story. This view overlooks a serious shortcoming in the drug patent system: the standards by which drugs are deemed unpatentable under the novelty and non-obviousness requirement bear little relationship to the social value of those drugs or the need for a patent to motivate their development. If the idea for a drug is not novel or is obvious, perhaps because it was disclosed in an earlier publication or made to look obvious by recent scientific advances, then it cannot be patented. Yet the mere idea for a drug alone is generally of little value to the public. Without clinical trials proving the drug's safety and efficacy, a prerequisite for FDA approval and acceptance by the medical community, it is unlikely to benefit the public. Given the immense investment needed to fund clinical trials on drugs, and the ability of generic manufacturers to rely on those tests to secure regulatory approval for their own products, pharmaceutical companies are rarely willing to develop a drug without patent protection. The novelty and non-obviousness requirements make no concession for the development costs of inventions, and thus withhold patents from drugs that are unlikely to reach the public without that protection. This gap in the patent system for drugs has created a pervasive problem in the pharmaceutical industry, causing firms to regularly screen through their......

Words: 299 - Pages: 2


...The pharmaceutical industry has had to adjust their marketing strategy due to the 1984 Food and Drug Administration (FDA) legislation regarding drug patent protection. Traditional market strategy has also been affected by the changing face of the consumer. Drug companies have begun advertising to consumers. In the past, marketing strategy centered on marketing to doctors. The doctors were provided samples which they made available to patients. The nonmarket environment has affected the efficiency of the pharmaceutical industry. Consumers are more knowledgeable and they have more access to means of communication than they have in the past. Pharmaceutical companies are marketing their products to a consumer group that is more aware of ailments and the benefits of pharmaceutical treatment. Pharmaceutical industries traditional marketing plan includes providing samples of medicines to doctors. The industry also provides auxiliary office items (such as pen and personalized stationary) to medical professionals. The successful national and international sale of these samples funds the development of new pharmaceutical products. It is a cycle that must be completed due to the nature of selling doctor prescribed pharmaceutical products. Because of stringent oversight of the Food and Drug Administration, the pharmaceutical industry spends millions of dollars on research. Tang (2013) notes, on average developing a new drug has become increasingly expensive, time consuming and risky......

Words: 391 - Pages: 2

Industry Trends for the Pharmaceutical Industry

...Industry Trends According to Standard and Poor’s industry service, in the past few years, the pharmaceutical industry has been subjected to heightened competition from generic drugmakers, unprecedented pricing pressure from payers, and hard-to-control inflation in research and development budgets. Furthermore, the  industry has been experiencing a decline in R&D productivity, with a lack of innovative new products being launched in recent years. The industry has suffered due to these problems in 2010, however, improvements in early-stage product pipelines in certain fields, such as cancer and diabetes, show positive long-term potential. Major cost-cutting initiatives, including sales and marketing overhauls and the reorganization of R&D operations, have been introduced as a response to the industry's concerns. New products, as well as an aging population, also provide another indication that the industry has a promising future. 1. Emerging Markets Drive Growth With markets in major developed nations being stagnant or only showing modest growth, pharmaceutical manufacturers are focusing on global emerging markets to provide momentum for industry growth over the coming years. Projections show that these markets will account for over two-fifths of global GDP, and 80% of the world's population by 2015. With respect to the pharmaceutical industry, observers have forecast that emerging markets will drive up to 90% of the sector's growth through 2020. Based on IMS...

Words: 2026 - Pages: 9

Patents and Aids, a Deadly Combination

...Patents and AIDS, a Deadly Combination AIDS in this age is an unfortunately ignored topic. The number of HIV and AIDS patients in the United States is steadily increasing each year. The age of those infected is becoming younger as well and little media attention is being directed at those affected by this disease. The increase of HIV infection is becoming parallel to the lack of proper sex education in schools across the country. With a lack of education in the country about safe sex, HIV infection undoubtedly will increase. Due to lack of government intervention on the topic, the people must begin to increase their own level of intervention. The patent was designed for the protection of financial investment. When it comes to pharmaceuticals, there is no more perfect example to the destructive power of patents. Amazingly, there are drugs which suppress the HIV virus and allow its victims to live a life as long as any other person. In the United States however, patents exist which allow for pharmaceutical companies to increase the price for their manufactured drugs to an irresponsible amount. For each year, an HIV/AIDS victim must pay between $2,100 to $11,815 dollar each year. The most common population of HIV/AIDS victims earn near minimum wage, which is about $14,000 per year if working 40 hours each week. The cost involved in being a victim of a virus such as HIV/AIDS is incredibly high in the United States. Due to the relation of HIV/AIDS infection in the United......

Words: 380 - Pages: 2

Patent Games: Plavix Case Study

...Running head: Patent Games: Plavix Patent Games: Plavix Case Study Columbia Southern University – DBA 7035 Patent Games: Plavix Case Study This paper will take a close look at some of the issues surrounding Apotex in the early 2000s. This company was working increasingly hard to break into the U.S. Market with their generic version of clopidogrel bisulfate, also known as Plavix. In addition, this paper will also explore how Sanofi-Aventis and Bristol-Meyers tried to maximize on forming monopolies to wean out their competitors, but instead caused more issues for their companies and how they FTC and state attorneys could have also shown a little more control and flexibility in making this agreement work for each party. Q1. Why did Bristol-Myers Squibb and Sanofi-Aventis seek a settlement rather than let the patent infringement case go to trial? The reason why Bristol-Myers Squibb and Sanofi-Aventis decided to seek a settlement could easily be because the patent infringement could have easily costs the companies more money if it were set to go to trial. In many instances, businesses pay more money by going directly to trial than settling out of court for a better result. Baron states, “Bristol-Myers Squibb and Sanofi – Aventis also agreed to pay Apotex at least $40 million if the agreement were approved and a $60 million break – up fee if the agreement would not receive antitrust approval” (Baron, 2010, p. 407). This settlement allowed Bristol Myers and......

Words: 1279 - Pages: 6


...Ruth Lindegarde Colorado Technical University Online August 24, 2014 Repost Professor Timothy Tapp; Applied Managerial Healthcare Finance, Professor Kristaizell Darby: Management the Healthcare Organization (HCM612-1401B-01), Professor Jenson Hagen: ECON616-1402A-0 Applied Managerial Economics, and Professor Kristy Taylor: Systems in Healthcare (HCM632-1403A-01) Abstract Pharmaceutical comes from Greek word “Pharmakeia” with the modern translation as “Pharmacia”. Many people owe their lives to many lifesaving medicines, without which they might not have seen another day in their life. Pharmaceutical companies are responsible for discovering new drugs, marketing them and getting them licensed for their use as medications. All drugs so produced have to go through a strict process of patenting and testing and are subjected to all sorts of safety checks and a variety of laws and regulations. These pharmaceutical companies not only play a very important role in the medicine industry but also play a significant role in the revenue industry and the development of a nation. Here are top 10 pharmaceutical companies in world. The global economic crisis is impacting every area of business and forcing corporations to reevaluate how they conduct operations. In an effort to operate in the leanest most efficient manner, some corporations are merging operations to provide better service with greater flexibility at a lower cost. Merck and Schering Plough are two......

Words: 4970 - Pages: 20

Pharmaceutical Industry

...real threats for Pharmaceutical industry as these movements focus on green environments and reduce chemicals and carbon which comes from pharmaceutical industries. It is not being possible to ignore these issues as they are supposed to be practiced under United Nation charter for clean and better environment. For example Pfizer is a well reputed British Pharmaceutical company which has aims to save the environment as much as possible from chemicals, waste water which includes active pharmaceutical ingredients mixture of different compounds and carbon which comes from their pharmaceutical industries. Different strategies could be used to reduce carbon and chemical waste from drugs for human environment, like proper consumption ,good way of savages for hospitals waste water like advance waste water treatment technology, private house hold expire drugs, training and education of medical professionals to reduce over prescription, and public education and awareness. These strategies could be help full for save green house environment from drugs. In conclusion if we do focus on three principal strategies to reduce the input of chemicals compounds, carbon, and waste water in to the environment are substitution of complex chemical compounds, advance technical approach, and proper education and training of doctors, retailers and consumers. (Klaus Kümmerer, 2009) Social The social life, physical activities and level of health of a community affects the pharmaceutical industry.......

Words: 1468 - Pages: 6


...INTRODUCTION Pharmaceuticals industry has a key role in manufacturing and developing new vaccines and drugs with an objective to improve life and prevention of diseases. Pharmaceutical industry have involvement in research and development, dealing in research and generation of new drugs, bulk manufacturing involving production of already existed drugs and in marketing. In spite of the fact that pharmaceutical industry is subjected to high risk and challenging business conditions as compared to any other industry. It has made tremendous contribution in improving global health. (IFPMA, 2012) “ Pharmaceutical industry spends more on research and development, relative to its sales revenue, than almost any other industry in the United States. According to various estimates, the industries’ real spending on drug R&D has grown between threefold and six fold over the past 25 years and that rise has been closely matched by growth in drug sales”(CBO, 2006). The research and development based pharmaceutical industries invest billions of dollars for development of a single drug and on an average the annual spending by the pharmaceutical industry is five times greater than that of the aerospace and defense industries, 4.5 times more than that of the chemicals industry, and 2.5 times more than that of the software and computer services industry”(IFPMA, 2012). IMPACT ON GLOBAL HEALTH & ECONOMY Pharmaceuticals research and drugs showed a remarkable performance in...

Words: 1954 - Pages: 8


...11 February 2015 Intellectual property: Case study PATENTS First, I would make my own research about if there are already existing products that may be similar to my invention. If I would be very sure of the novelty of the product, I would go to the National patent office in Latvia, fill in the legal documents and register for the patent grant. However, already at this point I would meet the first risk – the procedure what to demand from the lawyers. Knowing the specific matters about the Patent office of Latvia, I would consult about what should be done to gain the maximum information and protection from registering the patent. Due the fact that prior arts are a global matter, the issue should be demanded to be researched prom the lawyer’s side so that in future less problems can arise. It is important to remember that the application form would clearly form the problem that has been solved, public’s interest in finding a solution of this problem and the novelty of the solution itself. Also point out that the product will be used in any kind of industries (for example, security service/ life guards in mountains etc.). It is very important to educate the reader about the matter of the patent due the fact that misinterpretation could lead to the failure of the registration, for example, if the application focuses on the design approach of the scarf rather than the unusual manner or procedure etc., it may accrue that application is rejected as being identified as an......

Words: 403 - Pages: 2


...CASE TEACHING NOTES The Global Pharmaceutical Industry Sarah Holland (Manchester Business School) and Bernardo Bátiz-Lazo (London South Bank University) 1. Introduction The case describes how the prescription pharmaceutical industry has changed since its modern beginnings in the early 1950s. The various forces affecting the competitive environment of the industry are discussed in terms of origins, immediate past and immediate future (2004 onwards). As a result, the note provides insights into the evolution of barriers to enter and exit the industry for prescription pharmaceuticals, while aiming to help students to recognise how to set boundaries for an industry. This is a detailed industry note on the “ethical” pharmaceutical industry which provides an opportunity to analyse key success factors of major players. The note centres on a descriptive overview of the predominant issues in the three major Triad market areas: the US, Europe and Japan (although major issues in emerging markets are also mentioned). The note covers the overall industry environment with in-depth discussion of the driving forces in the industry such as globalisation (in particular global regulatory issues, changing world demographics and worldwide pricing disparities); development of new technology; the importance of time to market; and amalgamations. The case also examines issues around corporate social responsibility. 2. Position of the Case The pharmaceutical industry case study lends......

Words: 8602 - Pages: 35

Issues Surrounding Patents for Pharmeceuticals

...Date: 5/4/12 To: Lead Economist Laura From: Nate Thompson Subject: Hiring Manager Hannah Labor | Output | Fixed Cost | Variable Cost | Total Cost | Marginal Cost | 0 | 0 | $76.00 | $0 | $76 | $0 | 1 | 3 | $76.00 | $64.00 | $140.00 | $21.33 | 2 | 8 | $76.00 | $128.00 | $204.00 | $12.80 | 3 | 15 | $76.00 | $192.00 | $268.00 | $9.14 | 4 | 20 | $76.00 | $256.00 | $332.00 | $12.80 | 5 | 22 | $76.00 | $320.00 | $396.00 | $32.00 | Marginal revenue is equal to product price if this firm is in a perfectly competitive market. Since this is a perfectly competitive market, assume marginal revenue and prices both are equal to $25.00 1) Should output be increased from 15 to 20 (should the 4th worker be hired?) Due to the fact that the marginal cost has increased my answer is yes. 2) Should output be increased from 20 to 22 (should the 5th worker be hired?) Due to the fact that the marginal cost has increased my answer is yes. 3) Calculate profit for the last three levels of labor: * Calculate profit assuming output is 15: 15 times 25 equals 375. 375 minis 268 equals a $107.00 profit. * Calculate profit assuming output is 20: 20 times 25 equals 500. 500 minus 332 equals a $168.00 profit. * Calculate profit assuming output is 22: 22 times 25 equals 550. 550 minus 396 equals a $154.00 profit. 4) How many workers should Hannah employ and how much output should be produced each day, assuming the firm’s goal to maximize profit? Hannah should......

Words: 284 - Pages: 2

Viagra Patent

...has applied for FDA approval to market Revatio for use in children; an FDA decision is expected in May. Federal law provides for such extensions of exclusivity as an incentive for drug makers to test products that may be helpful to children. During exclusivity periods, competing generic copies are generally prohibited from entering the market. The FDA granted the six-month pediatric extension for sildenafil on Feb. 9, according to the FDA website. The patent extension applies to any drug containing sildenafil, even Viagra, which is only approved for use by men with erectile dysfunction and not for use by children. As a result, the U.S. period of exclusivity for Viagra would extend by six months until April 2020, said Pfizer spokeswoman Victoria Davis. That is based on a patent due to expire in 2019, which covers sildenafil's use to treat ED. This patent was upheld by a federal judge last year, though Teva Pharmaceutical Industries Ltd. (TEVA), which challenged the patent's validity, has appealed that decision. The basic patent for sildenafil was due to expire in March 2012. The pediatric exclusivity period now extends to September....

Words: 254 - Pages: 2